glp-1 antidepressant Study finds receptor agonist use increases likelihood of prescription GLP-1 Drugs and the Physiology

Only one such medication is available on the US market in two formulations: tirzepatide (Mounjaro, Zepound)

Participants taking the highest weekly dose of retatrutide lost, on average, 28% of their body weight, about 70 pounds, with nearly half losing 30% or more

Common GLP-1 Medications include: Semaglutide: Ozempic (Injection): Approved for Type 2 diabetes Wegovy (Injection): Approved for weight loss Rybelsus (Oral Tablet): Approved for Type 2 diabetes Tirzepatide (Note: Dual GLP-1/GIP receptor agonist): Mounjaro (Injection): Approved for Type 2 diabetes Zepbound (Injection): Approved for weight loss Liraglutide: Victoza (Injection): Approved for Type 2 diabetes Saxenda (Injection): Approved for weight loss Dulaglutide: Trulicity (Injection): Approved for Type 2 diabetes Exenatide: Byetta (Injection, short-acting) Bydureon BCise (Injection, long-acting) Lixisenatide: Adlyxin (Injection) Do GLP-1 Medications Help Cosmetic Surgery

DSIP vs melatonin Melatonin adjusts circadian timing